PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
PRDS
Delisted
PRDS was delisted on the 30th of August, 2023.
41 hedge funds and large institutions have $573M invested in Pardes Biosciences, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
53% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 36
Holders
41
Holding in Top 10
7
Calls
–
Puts
–
Top Buyers
| 1 | +$144M | |
| 2 | +$40.2M | |
| 3 | +$34.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.1M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$20.1M |
Top Sellers
| 1 | -$14M | |
| 2 | -$10.5M | |
| 3 | -$9.95M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9M |
| 5 |
SRCM
Sage Rock Capital Management
New York
|
-$6.62M |